The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Anterior Cingulate Cortexγ-Aminobutyric Acid in Depressed Adolescents: Relationship to Anhedonia
Open accessAbstract
CONTEXT: Anhedonia, a core symptom of major depressive disorder (MDD) and highly variable among adolescents with MDD, may involve alterations in the major inhibitory amino acid neurotransmitter system of γ-aminobutyric acid (GABA). OBJECTIVE: To test whether anterior cingulate cortex (ACC) GABA levels, measured by proton magnetic resonance spectroscopy, are decreased in adolescents with MDD. The associations of GABA alterations with the presence and severity of anhedonia were explored. DESIGN: Case-control, cross-sectional study using single-voxel proton magnetic resonance spectroscopy at 3 T. SETTING: Two clinical research divisions at 2 teaching hospitals. PARTICIPANTS: Twenty psychotropic medication-free adolescents with MDD (10 anhedonic, 12 female, aged 12-19 years) with episode duration of 8 weeks or more and 21 control subjects group matched for sex and age. MAIN OUTCOME MEASURES: Anterior cingulate cortex GABA levels expressed as ratios relative to unsuppressed voxel tissue water (w) and anhedonia scores expressed as a continuous variable. RESULTS: Compared with control subjects, adolescents with MDD had significantly decreased ACC GABA/w (t = 3.2; P < .003). When subjects with MDD were categorized based on the presence of anhedonia, only anhedonic patients had decreased GABA/w levels compared with control subjects (t = 4.08; P < .001; P(Tukey) < .001). Anterior cingulate cortex GABA/w levels were negatively correlated with anhedonia scores for the whole MDD group (r = -0.50; P = .02), as well as for the entire participant sample including the control subjects (r = -0.54; P < .001). Anterior cingulate cortex white matter was also significantly decreased in adolescents with MDD compared with controls (P = .04). CONCLUSIONS: These findings suggest that GABA, the major inhibitory neurotransmitter in the brain, may be implicated in adolescent MDD and, more specifically, in those with anhedonia. In addition, use of a continuous rather than categorical scale of anhedonia, as in the present study, may permit greater specificity in evaluating this important clinical feature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An imbalance between two primary central nervous system (CNS) neurotransmitters, L-glutamate and γ-aminobutyric acid (GABA), has emerged as having a key role in the pathophysiology of TRD.”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glutamatergic and GABAergic dysfunction in the prefrontal cortex (PFC) and anterior cingulate cortex (ACC) has been extensively implicated in both MDD and TRD [16,17,18,19,20,21,22,23,24,25].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [19]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both MDD and TRD, region-specific normalization of GABA concentrations in the occipital cortex (OCC), ACC, and DMN have repeatedly been observed in response to all successful antidepressant therapies [19,22,23,63].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [19]
Experimental — accuracy not yet measuredIn the citing paper
“Several human MRS studies have reported lower mPFC GABA levels in MDD (139–141).”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [140]
In the citing paper
“In the CNS, reductions in ACC GABA levels appear to correlate with increased anhedonia and treatment resistance [19,23].”
From Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression (2023) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
The mesolimbic dopamine reward circuit in depression
Nestler, E. J., & Carlezon, W. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.09.018 · Cited by 2,059
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
Bak, L. K., Schousboe, A., & Waagepetersen, H. S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03913.x · Cited by 1,114
Cingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R. V., Epperson, C. N., Wu, Y., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Widiger, T. A., & Samuel, D. B. (2005) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.114.4.494 · Cited by 752
Research works printed but not linked: 1
- [34]Sailasuta N LeRoux P Hurd R Wang P Sachs N Ketter T Detection of cerebral gamma-aminobutyric acid (GABA) in bipolar disorder patients and healthy volunteers at 3 T. In Proceedings of the ISMRM Annual Meeting 6 Berkeley, CA ISMRM 2001 1011
Cited by
Sorted by citations
Edden, R. A. E., Puts, N. A. J., Harris, A. D., Barker, P. B., & Evans, J. (2013) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.24478 · Cited by 625
Belleau, E. L., Treadway, M. T., & Pizzagalli, D. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.031 · Cited by 550
Lener, M. S., Niciu, M. J., Ballard, E. D., Park, M., Park, L. T., Nugent, A. C., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.005 · Cited by 468
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396
Dysfunctional reward processing in depression
Admon, R., & Pizzagalli, D. A. (2015) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2014.12.011 · Cited by 343
Fee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Schür, R. R., Draisma, L. W. R., Wijnen, J. P., Boks, M. P., Koevoets, M., Joëls, M., Klomp, D. W. J., Kahn, R. S., & Vinkers, C. H. (2016) · Human Brain Mapping · doi:10.1002/hbm.23244 · Cited by 372
Trial of SAGE-217 in Patients with Major Depressive Disorder
Gunduz-Bruce, H., Silber, C., Kaul, I., Rothschild, A. J., Riesenberg, R., Sankoh, A. J., Li, H., Lasser, R., Zorumski, C. F., Rubinow, D. R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1815981 · Cited by 232
Prévot, T. D., & Sibille, E. L. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0727-3 · Cited by 238
Striatum-Based Circuitry of Adolescent Depression and Anhedonia
Gabbay, V., Ely, B. A., Li, Q., Bangaru, S. D., Panzer, A. M., Alonso, C. M., Castellanos, F. X., & Milham, M. P. (2013) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.04.003 · Cited by 222
Self-citationCanetta, S., Bolkan, S., Padilla-Coreano, N., Song, L. J., Sahn, R., Harrison, N. L., Gordon, J. A., Brown, A., & Kellendonk, C. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.222 · Cited by 201
Godfrey, K. E. M., Gardner, A. C., Kwon, S., Chea, W., & Muthukumaraswamy, S. D. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.08.015 · Cited by 218
Fuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
Neurosteroids, stress and depression: Potential therapeutic opportunities
Zorumski, C. F., Paul, S. M., Izumi, Y., Covey, D. F., & Mennerick, S. J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.10.005 · Cited by 204
Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play
Savitz, J. B., Rauch, S. L., & Drevets, W. C. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.25 · Cited by 192
Sex differences in mood disorders: Perspectives from humans and rodent models
Seney, M. L., & Sibille, E. (2014) · Biology of Sex Differences · doi:10.1186/s13293-014-0017-3 · Cited by 181
Davey, C. G., Harrison, B. J., Yücel, M., & Allen, N. B. (2012) · Psychological Medicine · doi:10.1017/s0033291712000323 · Cited by 176
Silveri, M. M., Sneider, J. T., Crowley, D. J., Covell, M. J., Acharya, D., Rosso, I. M., & Jensen, J. E. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.01.033 · Cited by 175
Glutamate and GABA Homeostasis and Neurometabolism in Major Depressive Disorder
Sarawagi, A., Soni, N. D., & Patel, A. B. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.637863 · Cited by 184
Wang, S., Leri, F., & Rizvi, S. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110289 · Cited by 171
Major Depression: One Brain, One Disease, One Set of Intertwined Processes
Filatova, E. V., Shadrina, M. I., & Slominsky, P. A. (2021) · Cells · doi:10.3390/cells10061283 · Cited by 186
Pharmacotherapy of Postpartum Depression: Current Approaches and Novel Drug Development
Frieder, A., Fersh, M., Hainline, R., & Deligiannidis, K. M. (2019) · CNS Drugs · doi:10.1007/s40263-019-00605-7 · Cited by 156
GABAergic Control of Depression-Related Brain States
Luscher, B., & Fuchs, T. (2015) · Advances in Pharmacology · doi:10.1016/bs.apha.2014.11.003 · Cited by 149
Gabbay, V., Johnson, A. R., Alonso, C. M., Evans, L. K., Babb, J. S., & KLEIN, R. G. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0105 · Cited by 148
Self-citationCutler, A. J., Mattingly, G. W., & Maletic, V. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02514-2 · Cited by 156
Northoff, G., & Sibille, E. L. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.68 · Cited by 148
Effects of Physical Exercise on Depressive Symptoms and Biomarkers in Depression
Archer, T., Josefsson, T., & Lindwall, M. (2015) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141130203245 · Cited by 151
Sequeira‐Cordero, A., Salas-Bastos, A., Fornaguera, J., & Brenes, J. C. (2019) · Scientific Reports · doi:10.1038/s41598-019-53624-1 · Cited by 151
Simpson, H. B., Shungu, D. C., Bender, J., Mao, X., Xu, X., Slifstein, M., & Kegeles, L. S. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.132 · Cited by 138
Banasr, M., Lepack, A., Fee, C., Duric, V., Maldonado-Aviles, J., DiLeone, R., Sibille, E., Duman, R. S., & Sanacora, G. (2017) · Chronic Stress · doi:10.1177/2470547017720459 · Cited by 135
Sheth, C. S., McGlade, E., & Yurgelun-Todd, D. A. (2017) · Chronic Stress · doi:10.1177/2470547017715645 · Cited by 147
Lüscher, B., & Möhler, H. (2019) · F1000Research · doi:10.12688/f1000research.18758.1 · Cited by 105
Ren, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.009 · Cited by 114
Social vs. environmental stress models of depression from a behavioural and neurochemical approach
Vénzala, E., Garcia‐García, Á. L., Elizalde, N., & Tordera, R. M. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.05.010 · Cited by 122
Abdallah, C. G., Averill, C. L., Salas, R., Averill, L. A., Baldwin, P. R., Krystal, J. H., Mathew, S. J., & Mathalon, D. H. (2017) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.04.006 · Cited by 111
GABA System in Schizophrenia and Mood Disorders: A Mini Review on Third-Generation Imaging Studies
Chiapponi, C., Piras, F., Piras, F., Caltagirone, C., & Spalletta, G. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00061 · Cited by 109
Rosso, I. M., Weiner, M. R., Crowley, D. J., Silveri, M. M., Rauch, S. L., & Jensen, J. E. (2014) · Depression and Anxiety · doi:10.1002/da.22155 · Cited by 101
Henderson, S. E., Johnson, A. R., Vallejo, A. I., Katz, L., Wong, E. W., & Gabbay, V. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00152 · Cited by 106
Self-citationLener, M. S., & Iosifescu, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12759 · Cited by 101
Romeo, B., Choucha, W., Fossati, P., & Rotge, J.-Y. (2018) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.160228 · Cited by 94
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01728-8 · Cited by 101
Stress, sensitive periods, and substance abuse
Andersen, S. L. (2019) · Neurobiology of Stress · doi:10.1016/j.ynstr.2018.100140 · Cited by 92
Anterior cingulate cortex γ-aminobutyric acid deficits in youth with depression
Gabbay, V., Bradley, K., Mao, X., Ostrover, R., Kang, G., & Shungu, D. C. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.187 · Cited by 92
Self-citationHo, N., & Sommers, M. S. (2013) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2013.02.001 · Cited by 88
Cheng, J., Dong, S., Yi, L., Geng, D., & Liu, Q. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.031 · Cited by 79
Treadway, M. T., & Pizzagalli, D. A. (2014) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-4-5 · Cited by 79
Pozzi, L., Dorocic, I. P., Wang, X., Carlén, M., & Meletis, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083879 · Cited by 74
γ-Amino butyric acid and glutamate abnormalities in adolescent chronic marijuana smokers
Prescot, A. P., Renshaw, P. F., & Yurgelun-Todd, D. A. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2013.02.028 · Cited by 73
Anhedonia in Depression and Schizophrenia: Brain Reward and Aversion Circuits
Liang, S., Wu, Y., Hanxiaoran, L., Greenshaw, A. J., & Li, T. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s367839 · Cited by 86
Abdallah, C. G., Jackowski, A., Sato, J. R., Mao, X., Kang, G., Cheema, R., Coplan, J. D., Mathew, S. J., & Shungu, D. C. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.04.025 · Cited by 67
Reward systems and cognitions in Major Depressive Disorder
Cléry-Melin, M.-L., Jollant, F., & Gorwood, P. A. P. M. (2018) · CNS Spectrums · doi:10.1017/s1092852918001335 · Cited by 73
Neuroinflammation, Early-Life Adversity, and Brain Development
Andersen, S. L. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000325 · Cited by 73
Lapidus, K. A. B., Gabbay, V., Mao, X., Johnson, A., Murrough, J. W., Mathew, S. J., & Shungu, D. C. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.03.056 · Cited by 69
Self-citationPerceived stress predicts altered reward and loss feedback processing in medial prefrontal cortex
Treadway, M. T., Buckholtz, J. W., & Zald, D. H. (2013) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2013.00180 · Cited by 72
Croarkin, P. E., Nakonezny, P. A., Husain, M. M., Melton, T., Buyukdura, J. S., Kennard, B. D., Emslie, G. J., Kozel, F. A., & Daskalakis, Z. J. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.24 · Cited by 65
Transcranial Magnetic Stimulation for Adolescent Depression
Croarkin, P. E., & MacMaster, F. P. (2019) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2018.07.003 · Cited by 65
Electroconvulsive therapy in treatment resistant depression
Subramanian, S., Lopez, R., Zorumski, C. F., & Cristancho, P. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120095 · Cited by 75
Scholl, J., & Klein-Flügge, M. C. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.09.050 · Cited by 69
Henje, E., Duncan, L. G., Ho, T. C., Connolly, C. G., LeWinn, K. Z., Chesney, M. A., Hecht, F. M., & Yang, T. T. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00630 · Cited by 68
Abdallah, C. G., Niciu, M. J., Fenton, L. R., Fasula, M. K., Jiang, L., Black, A. C., Rothman, D. L., Mason, G. F., & Sanacora, G. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000361078 · Cited by 61
Sex chromosome complement regulates expression of mood-related genes
Seney, M. L., Ekong, K. I., Ding, Y., Tseng, G. C., & Sibille, E. L. (2013) · Biology of Sex Differences · doi:10.1186/2042-6410-4-20 · Cited by 62
Rodent ketamine depression-related research: Finding patterns in a literature of variability
Polis, A. J., Fitzgerald, P. J., Hale, P. J., & Watson, B. O. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112153 · Cited by 63
Benson, K. L., Bottary, R. M., Schoerning, L., Baer, L., Gönenç, A., Jensen, J. E., & Winkelman, J. W. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.026 · Cited by 57
Lewis, C. P., Port, J. D., Blacker, C. J., Sonmez, A. I., Seewoo, B. J., Leffler, J. M., Frye, M. A., & Croarkin, P. E. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0792-z · Cited by 57
Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression
Ely, B. A., Nguyen, T. N. B., Tobe, R. H., Walker, A., & Gabbay, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.678709 · Cited by 57
Self-citationGabbay, V., Freed, R. D., Alonso, C. M., Senger, S., Stadterman, J., Davison, B. A., & Klein, R. G. (2018) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.17m11596 · Cited by 57
Self-citationZhang, D., Li, H.-J., Zhang, H., & Ye, X. (2022) · Food & Function · doi:10.1039/d2fo00811d · Cited by 52
Draganov, M., Vives‐Gilabert, Y., de Diego-Adeliño, J., Vicent-Gil, M., Puigdemont, D., & Portella, M. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.138 · Cited by 53
GABA System in Depression: Impact on Pathophysiology and Psychopharmacology
Vecchia, A. D., Arone, A., Piccinni, A., Mucci, F., & Marazziti, D. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666211115124149 · Cited by 55
Biological substrates underpinning diagnosis of major depression
Sibille, E. L., & French, B. J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000436 · Cited by 53
Understanding the effects of chronic benzodiazepine use in depression: a focus on neuropharmacology
Lim, B., Sproule, B. A., Zahra, Z., Sunderji, N., Kennedy, S. H., & Rizvi, S. J. (2020) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000316 · Cited by 50
Pharmacotherapies Targeting GABA-Glutamate Neurotransmission for Treatment-Resistant Depression
Vecera, C. M., C. Courtes, A., Jones, G., Soares, J. C., & Machado-Vieira, R. (2023) · Pharmaceuticals · doi:10.3390/ph16111572 · Cited by 48
“In the CNS, reductions in ACC GABA levels appear to correlate with increased anhedonia and treatment resistance [19,23].”
BackgroundAnhedonia and emotional word memory in patients with depression.
Liu, W.-H., Wang, L.-Z., Zhao, S.-H., Ning, Y.-P., & Chan, R. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.07.025 · Cited by 49
Ren, Z., Sahir, N., Murakami, S., Luellen, B. A., Earnheart, J. C., Lal, R., Kim, J. Y., Song, H., & Lüscher, B. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.07.019 · Cited by 47
Lukkes, J. L., Meda, S., Thompson, B. S., Freund, N., & Andersen, S. L. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.053 · Cited by 48
Iorfino, F., Hickie, I. B., Lee, R. S. C., Lagopoulos, J., & Hermens, D. F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0852-3 · Cited by 47
The use of hormonal contraceptive agents and mood disorders in women
Svendal, G., Berk, M., Pasco, J. A., Jacka, F. N., Lund, A., & Williams, L. J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.030 · Cited by 43
Stress to inflammation and anhedonia: Mechanistic insights from preclinical and clinical models
Boyle, C. C., Bower, J. E., Eisenberger, N. I., & Irwin, M. R. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105307 · Cited by 45
Stan, A. D., Schirda, C. V., Bertocci, M. A., Bebko, G. M., Kronhaus, D. M., Aslam, H. A., LaBarbara, E. J., Tanase, C., Lockovich, J. C., Pollock, M. H., et al. (2014) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2014.05.016 · Cited by 35
Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41
Narayan, G. A., Hill, K., Wengler, K., He, X., Wang, J., Yang, J., Parsey, R. V., & DeLorenzo, C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01730-4 · Cited by 43
Simmonite, M., Steeby, C. J., & Taylor, S. F. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.08.004 · Cited by 39
Henderson, S., Vallejo, A. I., Ely, B. A., Kang, G., Roy, A. K., Pine, D. S., Stern, E. R., & Gabbay, V. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.09.006 · Cited by 38
Self-citationIncreased ventricular cerebrospinal fluid lactate in depressed adolescents
Bradley, K., Mao, X., Case, J. A. C., Kang, G., Shungu, D. C., & Gabbay, V. (2016) · European Psychiatry · doi:10.1016/j.eurpsy.2015.08.009 · Cited by 38
Self-citationChen, F., du Jardin, K. G., Waller, J. A., Sánchez, C., Nyengaard, J. R., & Wegener, G. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.018 · Cited by 38
Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
Goubert, E., Altvater, M., Rovira, M.-N., Khalilov, I., Mazzarino, M., Sebastiani, A., Schaefer, M. K. E., Rivera, C., & Pellegrino, C. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00012 · Cited by 33
Exercise Ameliorates Fluoride-induced Anxiety- and Depression-like Behavior in Mice: Role of GABA
Cao, Q., Wang, J., Hao, Y., Fang-ye, Z., Fu, R., Yu, Y., Wang, J., Niu, R., Bian, S., & Sun, Z. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02678-2 · Cited by 34
Ho, T. C., Teresi, G. I., Segarra, J. R., Ojha, A., Walker, J. C., Gu, M., Spielman, D. M., Sacchet, M. D., Jiang, F., Rosenberg-Hasson, Y., et al. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642976 · Cited by 32
Functional domains as correlates of suicidality among psychiatric inpatients
Yaseen, Z. S., GALYNKER, I. I., Briggs, J., Freed, R. D., & Gabbay, V. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.066 · Cited by 32
Self-citationMesripour, A., Hajhashemi, V., & Kuchak, A. (2017) · Research in Pharmaceutical Sciences · doi:10.4103/1735-5362.199046 · Cited by 31
Willinger, D., Häberling, I. S., Ilioska, I., Berger, G. E., Walitza, S., & Brem, S. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1386984 · Cited by 32
Croarkin, P. E., Nakonezny, P. A., Husain, M. M., Port, J. D., Melton, T., Kennard, B. D., Emslie, G. J., Kozel, F. A., & Daskalakis, Z. J. (2013) · Brain stimulation · doi:10.1016/j.brs.2013.11.006 · Cited by 31
Oberman, L. M., Hynd, M., Nielson, D. M., Towbin, K. E., Lisanby, S. H., & Stringaris, A. K. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.642847 · Cited by 30
Rice, L. J., Lagopoulos, J., Brammer, M. J., & Einfeld, S. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32472 · Cited by 30
Bernardo, A. M., Lee, P., Marcotte, M. D., Mian, M. Y., Rezvanian, S., Sharmin, D., Kovačević, A., Savić, M. M., Cook, J. M., Sibille, E. L., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01360-y · Cited by 30
Yoshino, Y., Roy, B., & Dwivedi, Y. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.06.004 · Cited by 26
Reward function as an outcome predictor in youth with mood and anxiety symptoms
Liu, Q., Ely, B. A., Schwartz, J. J., Alonso, C. M., Stern, E. R., & Gabbay, V. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.074 · Cited by 28
Self-citationCortical inhibitory and excitatory correlates of depression severity in children and adolescents
Lewis, C. P., Nakonezny, P. A., Ameis, S. H., Voort, J. L. V., Husain, M. M., Emslie, G. J., Daskalakis, Z. J., & Croarkin, P. E. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.020 · Cited by 29
Han, Z., Wang, L., Zhu, H., Tu, Y., He, P., & Li, B. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115191 · Cited by 28
Persson, J., Wall, A. E., Weis, J., Gingnell, M., Antoni, G., Lubberink, M., & Bodén, R. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111327 · Cited by 27
Metadata
- Authors
- Gabbay, V.
- Affiliations
- NYU Langone Health (US)
- Corresponding author
- Gabbay, Vilma
- ORCID
- Gabbay, Vilma
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2012-02-01
- Volume
- 69
- Issue
- 2
- Pages
- 139
- ISSN
- 0003-990X (ISSN-L)
- PMC
- PMC3711232
- OpenAlex
- W2099029781
- Cited by
- 201
- References
- 67
- Citations by year
- 2026: 12 · 2025: 6 · 2024: 15 · 2023: 13 · 2022: 12 · 2021: 18 · 2020: 15 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 16 · 2015: 13 · 2014: 15 · 2013: 14 · 2012: 8
- FWCI
- 8.67
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (MH075895, MH077072, MH077072-03S1, K23MH077072, R01MH075895)
- National Center for Complementary and Integrative Health (R21AT002395, R21AT004576, AT004576, AT002395)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- anterior cingulate cortex, GABA, adolescent depression, anhedonia, major depressive disorder, white matter, 1H NMR
- MeSH terms
- Adolescent, Child, Cross-Sectional Studies, Major Depressive Disorder, Depressive Disorder, Major, Female, gamma-Aminobutyric Acid, Gyrus Cinguli, Humans, Magnetic Resonance Imaging, Male, Magnetic Resonance Spectroscopy, Case-Control Studies, Neurotransmitter Agents, Young Adult, Anhedonia, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review